Curculigoside Protects against Titanium Particle-Induced Osteolysis through the Enhancement of Osteoblast Differentiation and Reduction of Osteoclast Formation

Wear particle-induced periprosthetic osteolysis is mainly responsible for joint replacement failure and revision surgery. Curculigoside is reported to have bone-protective potential, but whether curculigoside attenuates wear particle-induced osteolysis remains unclear. In this study, titanium partic...

Full description

Saved in:
Bibliographic Details
Main Authors: Fangbing Zhu, Jianyue Wang, Yueming Ni, Wei Yin, Qiao Hou, Yingliang Zhang, Shigui Yan, Renfu Quan
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2021/5707242
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850233835194679296
author Fangbing Zhu
Jianyue Wang
Yueming Ni
Wei Yin
Qiao Hou
Yingliang Zhang
Shigui Yan
Renfu Quan
author_facet Fangbing Zhu
Jianyue Wang
Yueming Ni
Wei Yin
Qiao Hou
Yingliang Zhang
Shigui Yan
Renfu Quan
author_sort Fangbing Zhu
collection DOAJ
description Wear particle-induced periprosthetic osteolysis is mainly responsible for joint replacement failure and revision surgery. Curculigoside is reported to have bone-protective potential, but whether curculigoside attenuates wear particle-induced osteolysis remains unclear. In this study, titanium particles (Ti) were used to stimulate osteoblastic MC3T3-E1 cells in the presence or absence of curculigoside, to determine their effect on osteoblast differentiation. Rat osteoclastic bone marrow stromal cells (BMSCs) were cocultured with Ti in the presence or absence of curculigoside, to evaluate its effect on osteoclast formation in vitro. Ti was also used to stimulate mouse calvaria to induce an osteolysis model, and curculigoside was administrated to evaluate its effect in the osteolysis model by micro-CT imaging and histopathological analyses. As the results indicated, in MC3T3-E1 cells, curculigoside treatment attenuated the Ti-induced inhibition on cell differentiation and apoptosis, increased alkaline phosphatase activity (ALP) and cell mineralization, and inhibited TNF-α, IL-1β, and IL-6 production and ROS generation. In BMSCs, curculigoside treatment suppressed the Ti-induced cell formation and suppressed the TNF-α, IL-1β, and IL-6 production and F-actin ring formation. In vivo, curculigoside attenuated Ti-induced bone loss and histological damage in murine calvaria. Curculigoside treatment also reversed the RANK/RANKL/OPG and NF-κB signaling pathways, by suppressing the RANKL and NF-κB expression, while activating the OPG expression. Our study demonstrated that curculigoside treatment was able to attenuate wear particle-induced periprosthetic osteolysis in in vivo and in vitro experiments, promoted osteoblastic MC3T3-E1 cell differentiation, and inhibited osteoclast BMSC formation. It suggests that curculigoside may be a potential pharmaceutical agent for wear particle-stimulated osteolysis therapy.
format Article
id doaj-art-071ea6fcaec84cc6afcf179345728fc8
institution OA Journals
issn 2314-8861
2314-7156
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-071ea6fcaec84cc6afcf179345728fc82025-08-20T02:02:50ZengWileyJournal of Immunology Research2314-88612314-71562021-01-01202110.1155/2021/57072425707242Curculigoside Protects against Titanium Particle-Induced Osteolysis through the Enhancement of Osteoblast Differentiation and Reduction of Osteoclast FormationFangbing Zhu0Jianyue Wang1Yueming Ni2Wei Yin3Qiao Hou4Yingliang Zhang5Shigui Yan6Renfu Quan7Department of Orthopaedic Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009 Zhejiang Province, ChinaDepartment of Orthopaedics, Xiaoshan Traditional Chinese Medical Hospital, Hangzhou, 311201 Zhejiang Province, ChinaDepartment of Orthopaedics, Xiaoshan Traditional Chinese Medical Hospital, Hangzhou, 311201 Zhejiang Province, ChinaSchool of Medicine, Zhejiang University, Hangzhou, 310058 Zhejiang Province, ChinaDepartment of Orthopaedics, Xiaoshan Traditional Chinese Medical Hospital, Hangzhou, 311201 Zhejiang Province, ChinaDepartment of Orthopaedics, Xiaoshan Traditional Chinese Medical Hospital, Hangzhou, 311201 Zhejiang Province, ChinaDepartment of Orthopaedic Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009 Zhejiang Province, ChinaDepartment of Orthopaedics, Xiaoshan Traditional Chinese Medical Hospital, Hangzhou, 311201 Zhejiang Province, ChinaWear particle-induced periprosthetic osteolysis is mainly responsible for joint replacement failure and revision surgery. Curculigoside is reported to have bone-protective potential, but whether curculigoside attenuates wear particle-induced osteolysis remains unclear. In this study, titanium particles (Ti) were used to stimulate osteoblastic MC3T3-E1 cells in the presence or absence of curculigoside, to determine their effect on osteoblast differentiation. Rat osteoclastic bone marrow stromal cells (BMSCs) were cocultured with Ti in the presence or absence of curculigoside, to evaluate its effect on osteoclast formation in vitro. Ti was also used to stimulate mouse calvaria to induce an osteolysis model, and curculigoside was administrated to evaluate its effect in the osteolysis model by micro-CT imaging and histopathological analyses. As the results indicated, in MC3T3-E1 cells, curculigoside treatment attenuated the Ti-induced inhibition on cell differentiation and apoptosis, increased alkaline phosphatase activity (ALP) and cell mineralization, and inhibited TNF-α, IL-1β, and IL-6 production and ROS generation. In BMSCs, curculigoside treatment suppressed the Ti-induced cell formation and suppressed the TNF-α, IL-1β, and IL-6 production and F-actin ring formation. In vivo, curculigoside attenuated Ti-induced bone loss and histological damage in murine calvaria. Curculigoside treatment also reversed the RANK/RANKL/OPG and NF-κB signaling pathways, by suppressing the RANKL and NF-κB expression, while activating the OPG expression. Our study demonstrated that curculigoside treatment was able to attenuate wear particle-induced periprosthetic osteolysis in in vivo and in vitro experiments, promoted osteoblastic MC3T3-E1 cell differentiation, and inhibited osteoclast BMSC formation. It suggests that curculigoside may be a potential pharmaceutical agent for wear particle-stimulated osteolysis therapy.http://dx.doi.org/10.1155/2021/5707242
spellingShingle Fangbing Zhu
Jianyue Wang
Yueming Ni
Wei Yin
Qiao Hou
Yingliang Zhang
Shigui Yan
Renfu Quan
Curculigoside Protects against Titanium Particle-Induced Osteolysis through the Enhancement of Osteoblast Differentiation and Reduction of Osteoclast Formation
Journal of Immunology Research
title Curculigoside Protects against Titanium Particle-Induced Osteolysis through the Enhancement of Osteoblast Differentiation and Reduction of Osteoclast Formation
title_full Curculigoside Protects against Titanium Particle-Induced Osteolysis through the Enhancement of Osteoblast Differentiation and Reduction of Osteoclast Formation
title_fullStr Curculigoside Protects against Titanium Particle-Induced Osteolysis through the Enhancement of Osteoblast Differentiation and Reduction of Osteoclast Formation
title_full_unstemmed Curculigoside Protects against Titanium Particle-Induced Osteolysis through the Enhancement of Osteoblast Differentiation and Reduction of Osteoclast Formation
title_short Curculigoside Protects against Titanium Particle-Induced Osteolysis through the Enhancement of Osteoblast Differentiation and Reduction of Osteoclast Formation
title_sort curculigoside protects against titanium particle induced osteolysis through the enhancement of osteoblast differentiation and reduction of osteoclast formation
url http://dx.doi.org/10.1155/2021/5707242
work_keys_str_mv AT fangbingzhu curculigosideprotectsagainsttitaniumparticleinducedosteolysisthroughtheenhancementofosteoblastdifferentiationandreductionofosteoclastformation
AT jianyuewang curculigosideprotectsagainsttitaniumparticleinducedosteolysisthroughtheenhancementofosteoblastdifferentiationandreductionofosteoclastformation
AT yuemingni curculigosideprotectsagainsttitaniumparticleinducedosteolysisthroughtheenhancementofosteoblastdifferentiationandreductionofosteoclastformation
AT weiyin curculigosideprotectsagainsttitaniumparticleinducedosteolysisthroughtheenhancementofosteoblastdifferentiationandreductionofosteoclastformation
AT qiaohou curculigosideprotectsagainsttitaniumparticleinducedosteolysisthroughtheenhancementofosteoblastdifferentiationandreductionofosteoclastformation
AT yingliangzhang curculigosideprotectsagainsttitaniumparticleinducedosteolysisthroughtheenhancementofosteoblastdifferentiationandreductionofosteoclastformation
AT shiguiyan curculigosideprotectsagainsttitaniumparticleinducedosteolysisthroughtheenhancementofosteoblastdifferentiationandreductionofosteoclastformation
AT renfuquan curculigosideprotectsagainsttitaniumparticleinducedosteolysisthroughtheenhancementofosteoblastdifferentiationandreductionofosteoclastformation